Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.67 |
| ▸ | MMP9 | P14780 | 7/20 | 0.53 |
| ▸ | MMP2 | P08253 | 6/20 | 0.53 |
| ▸ | MMP13 | P45452 | 5/20 | 0.53 |
| ▸ | MMP8 | P22894 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | ELANE | P08246 | 1/20 | 0.43 |
| ▸ | MMP3 | P08254 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CRHBP | P24387 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butethal SCHEMBL2718536 | 0.98 | LMNA (0.64) | LMNAMMP9MMP2MMP13MMP8 | |
| SCHEMBL918796 | 0.94 | LMNA (0.64) | LMNAMMP9MMP2MMP13MMP8 | |
| SCHEMBL712742 | 0.92 | MMP9 (0.63) | LMNAMMP9MMP2MMP13MMP8 | |
| SCHEMBL4379822 | 0.92 | MMP9 (0.63) | LMNAMMP9MMP2MMP13MMP8 | |
| SCHEMBL4382583 | 0.92 | MMP9 (0.63) | LMNAMMP9MMP2MMP13MMP8 | |
| SCHEMBL4390355 | 0.92 | MMP9 (0.63) | LMNAMMP9MMP2MMP13MMP8 | |
| SCHEMBL1683293 | 0.91 | LMNA (0.58) | LMNAMMP9MMP2MMP13MMP8 | |
| SCHEMBL1641551 | 0.90 | MMP9 (0.61) | LMNAMMP9MMP2MMP13MMP8 | |
| Amobarbital SCHEMBL13723415 | 0.88 | LMNA (0.52) | LMNAMMP9MMP2MMP13MMP8 | |
| SCHEMBL4889487 | 0.86 | LMNA (0.73) | LMNAMMP9MMP2MMP13MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2750 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260041939-A1 | METHODS FOR THE TREATMENT OF HYPERTENSION VIA TRANSCRANIAL-FOCUSED-ULTRASOUND | SUNNYBROOK RES INST (CA) | 2026-02-12 | — | — | US | claimed |
| EP-3507371-B1 | COMPOSITIONS FOR TREATING DISEASES AND DISORDERS OF THE NERVOUS SYSTEM | UNIV RUTGERS (US) | 2026-01-28 | — | — | EP | claimed |
| US-20250249002-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL WOUND TREATMENT | CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECN (AR) | 2025-08-07 | — | — | US | claimed |
| US-12133922-B2 | Abuse resistant capsule | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2024-11-05 | — | — | US | claimed |
| EP-4232004-A1 | FRACTAL FORMULATIONS | Nanogyre Sprl (BE) | 2023-08-30 | — | — | EP | claimed |
| US-20230174613-A1 | METHODS AND COMPOSITIONS FOR TREATING DISEASES AND DISORDERS OF THE NERVOUS SYSTEM | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2023-06-08 | — | — | US | claimed |
| US-20230030204-A1 | Treatment of Type 1 Diabetes | Galvani Bioelectronics Limited (GB) | 2023-02-02 | — | — | US | claimed |
| US-11542315-B2 | Methods and compositions for treating diseases and disorders of the nervous system | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2023-01-03 | — | — | US | claimed |
| US-20220362160-A1 | ABUSE RESISTANT CAPSULE | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2022-11-17 | — | — | US | claimed |
| US-11464747-B2 | Abuse resistant capsule | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2022-10-11 | — | — | US | claimed |
| EP-1165048-A1 | COMPOSITIONS AND METHODS FOR IMPROVED DELIVERY OF IONIZABLE HYDROPHOBIC THERAPEUTIC AGENTS | Lipocine, Inc. (US) | 2002-01-02 | — | — | EP | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| EP-1067942-A1 | HIGH-ENERGY CYCLODEXTRIN COMPLEXES | Cyclops, EHF. (IS) | 2001-01-17 | — | — | EP | claimed |
| WO-2000059475-A1 | COMPOSITIONS AND METHODS FOR IMPROVED DELIVERY OF IONIZABLE HYDROPHOBIC THERAPEUTIC AGENTS | LIPOCINE, INC. (US) | 2000-10-12 | — | — | WO | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| WO-1999042111-A1 | HIGH-ENERGY CYCLODEXTRIN COMPLEXES | CYCLOPS, EHF. (IS) | 1999-08-26 | — | — | WO | claimed |
| US-4181719-A | Analgesic N-acetyl-para-aminophenyl N'-acetylaminothioalkanoates | STERLING DRUG INC. (US) | 1980-01-01 | — | — | US | claimed |
| US-4107153-A | Heat-resistant thermosetting polyimide resin | TOSHIBA CHEMICAL PRODUCTS CO., LTD. (JP) | 1978-08-15 | — | — | US | claimed |
| US-4097545-A | Heat-resistant thermosetting polyimide resin with bis-phenol-epichlorohydrin reaction product | TOSHIBA CHEMICAL PRODUCTS CO. LTD. (JA) | 1978-06-27 | — | — | US | claimed |